Table 1.
Peer-reviewed articles
| Author, Publication year | Location of data collection | Study objective | Study design | Sample size |
|---|---|---|---|---|
| Al-Tayyib, AA., 2014 [12] | Denver, CO | To assess knowledge of PrEP, willingness to use PrEP, and potential changes in risk behavior among HIV-negative participants reporting sexual activity with a male partner | Secondary analysis of National HIV Behavioral Surveillance System Surveys | 503 |
| Bauermeister, JA., 2013 [3] | National | To assess awareness of PrEP and PrEP-related beliefs regarding side effects, accessibility, and affordability among young MSM | Online survey | 1507 |
| Brooks, RA., 2012 [13] | Los Angeles, CA | To identify key themes relating to acceptability and future adoption of PrEP among HIV-negative MSM in serodiscordant relationships | Qualitative interviews and brief interviewer-administered survey | 50 |
| Brooks, RA., 2011 [14] | Los Angeles, CA | To identify factors that might facilitate or impede future adoption of PrEP among MSM in serodiscordant relationships | Qualitative semi-structured interviews | 50 |
| Cohen, SE., 2015 [15] | San Francisco, CA, Miami, FL and Washington, DC | To assess PrEP delivery and predictors of enrollment in a program offering 48 weeks of PrEP, among MSM and transgender women (TGW) | Interviewer-administered questionnaire | 557 |
| Eaton, LA., 2014 [16] | Unspecified city in South Eastern, US | To assess PrEP knowledge and use, heath care access experiences, race-based medical mistrust, sexual partners and behaviors, and drug and alcohol use, among Black MSM | In-person survey | 398 |
| Fuchs, JD., 2013 [17] | National; 21 HIV Vaccine Trials Network 505 trial sites | To assess intention to use PrEP among participants in an HIV vaccine efficacy trial | Online survey | 376 |
| Galindo, GR., 2012 [18] | Almeda, Los Angeles, and San Francisco, CA | To examine acceptability of individual daily PrEP, and assess potential barriers to community uptake, among MSM and TGW | Qualitative semi-structured interviews | 30 |
| Gilmore, HI., 2013 [19] | San Francisco, CA | To understand individual and contextual factors influencing PrEP use in iPrEx trial (phase III clinical trial to determine safety of tenofovir/emtricitabine) participants | Focus groups and qualitative in-depth interviews | 52 |
| Golub, SA., 2013 [20] | New York, NY | To examine facilitators and barriers to PrEP use and adherence and their association with PrEP acceptability, among MSM and TGW | Interview and computer-administered survey | 184 |
| Golub, SA., 2013 [21] | New York, NY | To examine associations between anticipated stigma and HIV testing behaviors among MSM and TGW | Online survey | 305 |
| Hosek, SG., 2013 [22] | New York, NY | To examine feasibility of a combination prevention intervention for young HIV-negative MSM | Focus groups and computer assisted self-interviews as participants completed a trial of PrEP (emtricitabine/tenofovir). | 58 |
| Krakower, DS., 2012 [23] | National | To assess PrEP awareness, interest and experience among at-risk MSM before and after iPrEx trial results (demonstrating that oral PrEP reduced the risk of HIV acquisition among high-risk MSM) were released to the public | Internet-based survey | 4956 |
| Rucinski, KB., 2013 [24] | New York, NY | To understand current PrEP knowledge and use among MSM | Online survey | 329 |
| Kubicek, K., 2015 [25] | Los Angeles, CA | To examine young MSM of color’s awareness and perceptions of PrEP and rectal microbicides | Focus group | 53 |
| Mimiaga, ML., 2014 [26] | Boston, MA | To explore perceived influences of sexual relationships on promoting and inhibiting PrEP use among high-risk MSM who report regular drug use | Qualitative semi-structured interviews | 40 |
| Meyers, K., 2014 [27] | New York, NY | To report the willingness of a racially-ethnically diverse cohort of young MSM to use long-acting injectable PrEP | Computer-assisted self-interviews | 197 |
| Mustanski, B., 2013 [28] | Chicago, IL | To assess interest in PrEP use under various conditions of side-effects, dosing, and effectiveness in young MSM | Audio computer assisted self-interview | 171 |
| Perez-Figueroa, RE. 2015 [29] | New York, NY | To examine attitudes and perceptions toward PrEP uptake among young MSM | Qualitative semi-structured interviews | 100 |
| Saberi, P., 2012 [30] | San Francisco, CA | To examine serodiscordant and seroconcordant male couple’s PrEP awareness, concerns regarding health care providers offering PrEP to the community, and correlates of PrEP uptake by the HIV-negative member of the couple | Mixed methods (qualitative interviews and quantitative survey) | 328 |
| Smith, DK., 2012 [31] | Atlanta, GA | To elicit attitudes about and service access preferences for daily oral antiretroviral PrEP from urban, Black, young men and women at risk for HIV transmission | Focus group | 77 |
| Snowden, JM., 2014 [32] | San Francisco, CA | To assess prevalence and correlates of seroadaptive behaviors and conventional risk reduction among MSM | Secondary data analysis of National HIC Behavioral Surveillance system surveys | 455 |
| Taylor, WS., 2014 [33] | Boston, MA | To identify targets for behavioral interventions to improve adherence to PrEP, among MSM who had been prescribed and used PrEP in the context of a clinical trial and high-risk MSM who had not previously used PrEP | Focus groups | 39 |
| Tripathi, A., 2013 [34] | Columbia, SC | To explore sociodemographic and behavioral factors associated with PrEP adoption among HIV seronegative MSM and heterosexual partners | Self-administered survey | 89 |
| Whiteside, YO. 2011 [35] | Ryan White HIV/AIDS Clinic, SC | To assess self-perceived risk of HIV infection and attitudes about PrEP among sexually transmitted disease clinic attendees | Self-administered survey | 405 |